ToolsGroup Recognized in the 2025 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions for the Second Consecutive Year
As a trusted partner to retailers, distributors, and manufacturers, ToolsGroup drives results in an uncertain world
BOSTON, MA / ACCESS Newswire / April 22, 2025 / ToolsGroup, a global leader in supply chain planning and optimization software, is proud to announce that it has been included in the 2025 Gartner Magic Quadrant for Supply Chain Planning Solutions for the second consecutive year.
For retailers, distributors, and manufacturers struggling to deliver results amidst uncertainty, ToolsGroup provides a breakthrough approach to supply chain planning that combines statistical modelling, advanced mathematical optimization, and AI. Customers have the power to shape demand and synchronize supply - replacing guesswork with precision.
Built on decades of expertise and a unique probabilistic approach, ToolsGroup's Supply Chain Planning capabilities cover everything from S&OP and demand planning to inventory optimization, replenishment, and transport analytics. Powered by AI and real-time data, ToolsGroup tackles complex supply chain challenges with better math and greater accuracy, all while ensuring simplicity and explainability.
"We're honored that Gartner continues to recognize us for supply chain planning," said ToolsGroup CEO, Sean Elliott. "We have a very clear objective: to help our customers deliver their promises. By providing unparalleled control of demand and supply across all time horizons, we enable companies to make optimal decisions that drive profitability, improve working capital efficiency and delight customers. Ultimately, we deliver certainty in a complex and variable world."
Get a complimentary copy of the Gartner Magic Quadrant for Supply Chain Planning Solutions here.
Meet us at the Gartner Supply Chain Symposium|Xpo
ToolsGroup, a global leader in supply chain planning and optimization software, will be in attendance at Gartner Supply Chain Symposium|Xpo™, taking place May 5-7 in Orlando. Attendees are invited to hear firsthand from ToolsGroup customer Belcorp, a leading multinational beauty company, as they share how ToolsGroup's technology helped them navigate the challenges of a fast-moving, high-SKU supply chain and drive transformation.
ToolsGroup will be at Booth #634 where attendees can engage with our experts to discover how smarter, more responsive supply chain planning can unlock new growth opportunities. Book a consultative session here https://www.toolsgroup.com/contact-us/.
About Gartner Supply Chain Symposium/Xpo
Gartner Supply Chain Symposium/Xpo is the premier gathering of trailblazers, thought leaders and industry experts pushing the boundaries of supply chain. Future-Focused. Value-Driven. Uncover the latest supply chain insights and solutions with experts, CSCOs, peers and service providers. Take three days to step away and discover inspiration, innovation and actionable insights necessary to drive future strategic and financial success.
Disclaimer
GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant, Gartner Supply Chain Symposium/Xpo and Magic Quadrant are a registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About ToolsGroup
ToolsGroup's innovative AI-powered solutions enable retailers, distributors and manufacturers to navigate through supply chain uncertainty. Our retail and supply chain planning suites empower a new level of intelligent decision-making and unlock powerful business improvements in forecast accuracy, service levels and inventory - delighting customers and achieving financial and sustainability KPIs. Stay in touch with ToolsGroup on LinkedIn, Twitter, and YouTube, or visit www.toolsgroup.com.
Media Contact
Escalate PR for ToolsGroup
toolsgroup@escalatepr.com
SOURCE: ToolsGroup
View the original press release on ACCESS Newswire
ToolsGroup
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Advances Community-Led Forest Protection in Colombia's Meta Region19.11.2025 15:00:00 CET | Press release
New phase of the Sur del Meta Project expands carbon and biodiversity monitoring while strengthening local governance and livelihoods. CALGARY, AB / ACCESS Newswire / November 19, 2025 / In the heart of Colombia's Meta department, where forests and farmlands converge, Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is deepening its commitment to people-powered climate solutions through the REDD+ Sur del Meta Project - a long-term conservation initiative that protects 40,637 hectares of natural forest while supporting sustainable livelihoods for nearly 1,000 local families. Developed through ALLCOT - A Karbon-X Company, the project development and advisory arm of Karbon-X, the initiative operates across the municipalities of Vistahermosa, Puerto Rico, Puerto Concordia, and Puerto Lleras, a region historically affected by deforestation and armed conflict. The project partners with local farmers, many of whom are victims of Colombia's armed conflict, helping them transition from
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom